← Back

Everolimus

product
Last discussed Sep 28, 2026

A rapalog (rapamycin analogue) mTOR inhibitor used as an immunosuppressant and in cancer treatment, also studied for potential geroprotective effects.

Recently discussed in

What creators say

Peter Attia
mentioned
Used for: Intermittent dosing strategy for mTORC1-selective inhibition vs: Compared to sirolimus; discussed as alternative to developing new mTORC1-sele...

"Do you think that just intermittent dosing of everolimus or sirolimus gets that — mTORC1 selective inhibition?"

409 ‒ Inside modern drug development: the science, econom... · ▶ 2:24:04 · Sep 28, 2026
More from Peter Attia →
+1 more mention from Peter

"When they published that paper in 2014 using everolimus, where they took a group of 65-year-olds and randomized them to either a placebo or differe..."

Supplements for Longevity & Their Efficacy | Dr. Peter Attia · Jul 29, 2024

Keep exploring

Longevity topic · 261 products Pharmaceuticals topic · 81 products

Topics

longevity pharmaceuticals medications immunity mtor geroprotection rapalogs

About this data

  • ✓50,000+ mentions extracted from real podcast transcripts
  • ✓Every quote links to the source episode
  • ✓Sponsored mentions are always labeled
  • ✓Critical takes are shown, never filtered out
How Followed works →
Get an email when a new creator recommends it

Follow Everolimus

Free email updates